Australia’s Therapeutic Goods Administration granted provisional approval for Wegovy to treat metabolic dysfunction-associated steatohepatitis in adults with moderate to advanced liver fibrosis (stage...
The Federal Government has launched a free telehealth therapy for emerging mental illness, offering LiCBT low intensity cognitive behavioural therapy for people 16 and older. Access is available witho...
At the Australian Financial Review Healthcare Summit, leaders debated the National Disability Insurance Scheme amid mounting cost pressures. Federal health minister Mark Butler acknowledged the scheme...
The federal government has rolled out a telephone based mental health support service called Medicare Mental Health Check In for Australians aged 16 and over who are experiencing mild distress such as...
Canberra's government unveiled a $10.5 million component of a $24.3 million package to deliver three bulk-billed general practices in the ACT. The Bulk Billing GP Attraction Initiative aims to guarant...
Federal health minister Mark Butler signalled a cautious but open path to subsidising GLP-1 obesity drugs on the PBS. He spoke at the AFR Healthcare Summit and framed these therapies as potentially tr...
The Australian Government has allocated $24.3 million to establish three bulk-billing GP clinics in the ACT and will back that with an extra $10.5 million through the Bulk Billing GP Attraction Initia...
Pembrolizumab, sold as Keytruda, will be listed on the PBS for three new cancer indications: locally advanced high‑risk cervical cancer that has spread beyond the cervix but not to distant sites; inte...
The Pharmaceutical Benefits Advisory Committee has laid out how GLP-1 obesity medicines could gain subsidised access through the PBS, with Wegovy front and centre. The plan calls for a slow and manage...
Novo Nordisk chief executive Mike Doustdar used a National Press Club address to urge broader PBS coverage of Ozempic for children with obesity. He framed expanded access as a way to accelerate early...
The PBAC has signalled a slow, staged PBS subsidy for GLP-1 receptor agonists used to treat obesity. The initial rollout targets high‑risk groups such as those with cardiovascular disease, Aboriginal...
The Health Minister announced a nationwide pharmacist-led prescribing trial that will subsidise pharmacists to the same PBS-eligible level as GPs for oral contraceptives and some antibiotics from Janu...
Australia will run a 12 month trial from January 2027 that lets concession card holders access pharmacy prescribed contraceptives and allows qualified pharmacists to treat uncomplicated UTIs without a...
The federal government will fund a nationwide pharmacist contraceptives trial. Federal health minister Mark Butler announced at the Australasian Pharmacy Professionals conference on the Gold Coast tha...
At the Australian Pharmacy Professional conference on the Gold Coast, Pharmacy Guild president Trent Twomey pressed for pharmacists to be able to autonomously prescribe and sell Schedule 2, 4 and 8 dr...
A Labor MP sent a targeted letter to a Victorian general practice, expressing disappointment that it is not operating as a fully bulk-billing clinic and urging a move to 100 per cent bulk-billing. The...
The Pharmacy Guild of Australia reportedly paid up to 110000 per year for a seat at a Canberra birthday dinner for Prime Minister Anthony Albanese and Federal Treasurer Jim Chalmers. The event doubled...
The Royal Australian College of General Practitioners (RACGP) is emphasising frontline GP advocacy through its GP Advocate Network, which now includes 151 members across Australia. Dr Jennie Wright, a...
From 1 March the PBS expands listings for nivolumab and ipilimumab. Nivolumab is Opdivo and ipilimumab is Yervoy. The price cap is $25 per course. The change is expected to save more than 5,000 Austra...
Australia announced a pan-tumour PBS listing for nivolumab and ipilimumab, enabling affordable combination immunotherapy for thousands of Australians with advanced or metastatic cancer. The listing me...
